Logo image of CAN

CANAAN INC (CAN) Stock Fundamental Analysis

NASDAQ:CAN - Nasdaq - US1347481020 - ADR - Currency: USD

0.8677  -0.1 (-10.59%)

After market: 0.88 +0.01 (+1.42%)

Fundamental Rating

3

We assign a fundamental rating of 3 out of 10 to CAN. CAN was compared to 32 industry peers in the Technology Hardware, Storage & Peripherals industry. CAN may be in some trouble as it scores bad on both profitability and health. CAN is valied quite expensively at the moment, while it does show a decent growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

In the past year CAN has reported negative net income.
CAN had a negative operating cash flow in the past year.
In multiple years CAN reported negative net income over the last 5 years.
In multiple years CAN reported negative operating cash flow during the last 5 years.
CAN Yearly Net Income VS EBIT VS OCF VS FCFCAN Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2017 2018 2019 2020 2021 2022 2023 2024 0 200M -200M -400M

1.2 Ratios

The Return On Assets of CAN (-54.00%) is worse than 84.38% of its industry peers.
With a Return On Equity value of -93.98%, CAN perfoms like the industry average, outperforming 40.63% of the companies in the same industry.
Industry RankSector Rank
ROA -54%
ROE -93.98%
ROIC N/A
ROA(3y)-42.47%
ROA(5y)-22.42%
ROE(3y)-67.02%
ROE(5y)-38.23%
ROIC(3y)N/A
ROIC(5y)N/A
CAN Yearly ROA, ROE, ROICCAN Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2017 2018 2019 2020 2021 2022 2023 2024 0 50 -50 -100 -150

1.3 Margins

CAN does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
CAN Yearly Profit, Operating, Gross MarginsCAN Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2017 2018 2019 2020 2021 2022 2023 2024 0 50 -50 -100 -150

More info and screens

3

2. Health

2.1 Basic Checks

CAN does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, CAN has more shares outstanding
The number of shares outstanding for CAN has been increased compared to 5 years ago.
The debt/assets ratio for CAN is higher compared to a year ago.
CAN Yearly Shares OutstandingCAN Yearly Shares OutstandingYearly Shares Outstanding 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M 500M
CAN Yearly Total Debt VS Total AssetsCAN Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M

2.2 Solvency

Based on the Altman-Z score of -0.57, we must say that CAN is in the distress zone and has some risk of bankruptcy.
With a Altman-Z score value of -0.57, CAN is not doing good in the industry: 75.00% of the companies in the same industry are doing better.
A Debt/Equity ratio of 0.03 indicates that CAN is not too dependend on debt financing.
Looking at the Debt to Equity ratio, with a value of 0.03, CAN is in the better half of the industry, outperforming 78.13% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.03
Debt/FCF N/A
Altman-Z -0.57
ROIC/WACCN/A
WACC8.88%
CAN Yearly LT Debt VS Equity VS FCFCAN Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2017 2018 2019 2020 2021 2022 2023 2024 0 200M -200M 400M 600M

2.3 Liquidity

CAN has a Current Ratio of 1.87. This is a normal value and indicates that CAN is financially healthy and should not expect problems in meeting its short term obligations.
CAN's Current ratio of 1.87 is fine compared to the rest of the industry. CAN outperforms 62.50% of its industry peers.
CAN has a Quick Ratio of 1.34. This is a normal value and indicates that CAN is financially healthy and should not expect problems in meeting its short term obligations.
CAN has a Quick ratio of 1.34. This is in the better half of the industry: CAN outperforms 65.63% of its industry peers.
Industry RankSector Rank
Current Ratio 1.87
Quick Ratio 1.34
CAN Yearly Current Assets VS Current LiabilitesCAN Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M

More info and screens

6

3. Growth

3.1 Past

CAN shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -45.28%.
The Revenue has grown by 27.20% in the past year. This is a very strong growth!
The Revenue has been growing slightly by 5.48% on average over the past years.
EPS 1Y (TTM)-45.28%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-1018.75%
Revenue 1Y (TTM)27.2%
Revenue growth 3Y-29.66%
Revenue growth 5Y5.48%
Sales Q2Q%135.9%

3.2 Future

The Earnings Per Share is expected to grow by 68.90% on average over the next years. This is a very strong growth
The Revenue is expected to grow by 88.42% on average over the next years. This is a very strong growth
EPS Next Y-168.17%
EPS Next 2Y68.9%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year116.81%
Revenue Next 2Y88.42%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
CAN Yearly Revenue VS EstimatesCAN Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 200M 400M 600M 800M
CAN Yearly EPS VS EstimatesCAN Yearly EPS VS EstimatesYearly EPS VS Estimates 2022 2023 2024 2025 2026 0 0.5 -0.5 -1 -1.5

More info and screens

3

4. Valuation

4.1 Price/Earnings Ratio

CAN reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Based on the Price/Forward Earnings ratio of 2.20, the valuation of CAN can be described as very cheap.
CAN's Price/Forward Earnings ratio is rather cheap when compared to the industry. CAN is cheaper than 93.75% of the companies in the same industry.
The average S&P500 Price/Forward Earnings ratio is at 35.33. CAN is valued rather cheaply when compared to this.
Industry RankSector Rank
PE N/A
Fwd PE 2.2
CAN Price Earnings VS Forward Price EarningsCAN Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20 30

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
CAN Per share dataCAN EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.5 -0.5 -1 -1.5 -2

4.3 Compensation for Growth

A more expensive valuation may be justified as CAN's earnings are expected to grow with 68.90% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y68.9%
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

CAN does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

CANAAN INC

NASDAQ:CAN (7/15/2025, 8:00:02 PM)

After market: 0.88 +0.01 (+1.42%)

0.8677

-0.1 (-10.59%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupTechnology Hardware & Equipment
GICS IndustryTechnology Hardware, Storage & Peripherals
Earnings (Last)05-20 2025-05-20/bmo
Earnings (Next)08-13 2025-08-13
Inst Owners20.65%
Inst Owner Change0%
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap399.46M
Analysts80
Price Target2.88 (231.91%)
Short Float %160.24%
Short Ratio1.16
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-179.43%
Min EPS beat(2)-434.65%
Max EPS beat(2)75.8%
EPS beat(4)3
Avg EPS beat(4)-63.09%
Min EPS beat(4)-434.65%
Max EPS beat(4)75.8%
EPS beat(8)3
Avg EPS beat(8)-86.14%
EPS beat(12)5
Avg EPS beat(12)-52.69%
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)2
Avg Revenue beat(2)1.19%
Min Revenue beat(2)0.05%
Max Revenue beat(2)2.33%
Revenue beat(4)4
Avg Revenue beat(4)13.6%
Min Revenue beat(4)0.05%
Max Revenue beat(4)37.08%
Revenue beat(8)6
Avg Revenue beat(8)9.03%
Revenue beat(12)8
Avg Revenue beat(12)49.49%
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-7.24%
PT rev (3m)-30.34%
EPS NQ rev (1m)0%
EPS NQ rev (3m)10.34%
EPS NY rev (1m)-564.65%
EPS NY rev (3m)-7109.54%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)4.41%
Revenue NY rev (1m)-18.24%
Revenue NY rev (3m)-17.64%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 2.2
P/S 1.48
P/FCF N/A
P/OCF N/A
P/B 1.5
P/tB 1.97
EV/EBITDA N/A
EPS(TTM)-2.09
EYN/A
EPS(NY)0.39
Fwd EY45.4%
FCF(TTM)-0.47
FCFYN/A
OCF(TTM)-0.43
OCFYN/A
SpS0.59
BVpS0.58
TBVpS0.44
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -54%
ROE -93.98%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-42.47%
ROA(5y)-22.42%
ROE(3y)-67.02%
ROE(5y)-38.23%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score4
Asset Turnover0.58
Health
Industry RankSector Rank
Debt/Equity 0.03
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 67.86%
Cap/Sales 7.04%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.87
Quick Ratio 1.34
Altman-Z -0.57
F-Score4
WACC8.88%
ROIC/WACCN/A
Cap/Depr(3y)38.45%
Cap/Depr(5y)94.83%
Cap/Sales(3y)3.6%
Cap/Sales(5y)2.4%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-45.28%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-1018.75%
EPS Next Y-168.17%
EPS Next 2Y68.9%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)27.2%
Revenue growth 3Y-29.66%
Revenue growth 5Y5.48%
Sales Q2Q%135.9%
Revenue Next Year116.81%
Revenue Next 2Y88.42%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y41.85%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year119.56%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-71.24%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-60.48%
OCF growth 3YN/A
OCF growth 5YN/A